Jefferies Raises price Target on Genomic Health (GHDX) Following Initial 2016 Outlook

Go back to Jefferies Raises price Target on Genomic Health (GHDX) Following Initial 2016 Outlook

Piper Jaffray Cuts Price Target on Genomic Health (GHDX) After 4Q Reports In-Line with Preliminary Results

February 11, 2016 9:15 AM EST

Piper Jaffray reiterated a Neutral rating on Genomic Health Inc. (NASDAQ: GHDX), and cut the price target to $31.00 (from $32.00), following the company's 4Q earnings report. Genomic Health announced 4Q15 revenue growth of 7.8% yoy to $74.5M, slightly above preliminary results ($73M-$74M). Management attributes... More

Genomic Health (GHDX) Misses Q4 EPS by 1c

February 10, 2016 4:39 PM EST

Genomic Health (NASDAQ: GHDX) reported Q4 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $74.5 million versus the consensus estimate of $74.03 million.

GUIDANCE:

Genomic Health sees FY2016 revenue of $320-335 million, versus the consensus of... More

Trading Radar for 2/10: Twitter (TWTR), Time Warner (TWX), Tesla (TSLA), Cisco (CSCO), Humana (HUM) Report

February 9, 2016 3:13 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
7:00am EST

MBA Mortgage Index - no Street consensus

Earnings:

ACCO Brands Corporation (Nasdaq: ACCO) - consensus EPS $0.28
ARM Holdings plc (Nasdaq: ARMH) - consensus EPS $0.38
AmTrust Financial (Nasdaq: AFSI) - consensus EPS $0.67
Aramark Services (Nasdaq: ARMK) - consensus EPS $0.49
Axalta Coating Systems (Nasdaq:... More